tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Haemonetics price target lowered to $72 from $87 at Baird

Baird lowered the firm’s price target on Haemonetics (HAE) to $72 from $87 and keeps an Outperform rating on the shares. The firm updated its model following its messy Q1 results which beat on weak IVT; but offsets should keep the 2026 guidance in check.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1